References
- 1. Kurdi MS, Jadhav RR, Ratkal, J, Kaur J, Ashwini HR, Hiregouder S, Deva R. The perioperative management of haemophilia: easier said than done. J Haem Pract 2014; 1O3P: 7N8.
- 2. Lövdahl S, Henriksson KM, Baghaei F, Holmström M, Nilsson JÅ, Berntorp E, Astermark J. Incidence, mortality rates and causes of deaths in haemophilia patients in Sweden. Haemophilia 2013; 19O3P: 362N9. doi: 10.1111/hae.12092.
- 3. Darby SC, Kan SW, Spooner RJ, Giangrande PL, Hill FG, Hay CR, et al. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 2007; 110O3P: 815N25.
- 4. Hermans C, de Moerloose P, Dolan G. Clinical management of older persons with haemophilia. Crit Rev Oncol Hematol 2014; 89O2P: 197N206. doi: 10.1016/j.critrevonc.2013.07.005.
- 5. Fischer K, Steen Carlsson K, Petrini P, Holmström M, Ljung R, van den Berg HM, Berntorp E. IntermediateNdose versus highNdose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s. Blood 2013; 122O7P: 1129N36. doi: 10.1182/bloodN2012N12N470898.
- 6. Viswabandya A, Mathews V, George B, Nair SC, Baidya S, Mammen JJ, Chandy M, Srivastava A. Successful surgical haemostasis in patients with von Willebrand disease with Koate DVI. Haemophilia 2008; 14O4P: 763N7. doi: 10.1111/j.1365N 2516.2008.01755.x.
- 7. Wu R, Luke KH, Poon MC, Wu X, Zhang N, Zhao L, Su Y, Zhang J. Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: a pilot study in China. Haemophilia 2011; 17O1P: 70N4. doi: 10.1111/j.1365N 2516.2010.02348.x.